ALB and metabolic dysfunction-associated steatotic liver disease: This study systematically evaluated the CALLY index as a comprehensive biomarker for NAFLD, comparing it to traditional approaches that rely on single biomarkers such as albumin, lymphocyte count, or CRP [18, 37, 38].